The effects of different doses of dexmedetomidine on the requirements for propofol for loss of consciousness in patients monitored via the bispectral index: a double-blind, placebo-controlled trial

BACKGROUND: The α(2)-adrenergic agonist dexmedetomidine (DEX) is a sedative and can be used as an adjunct to hypnotics. The study sought to evaluate the effects of different doses of DEX on the requirements for propofol for loss of consciousness (LOC) in patients monitored via the bispectral index (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Anesthesiol
Main Authors: Gu, Yang, Yang, Fan, Zhang, Yonghai, Zheng, Junwei, Wang, Jie, Li, Bin, Ma, Tao, Cui, Xiang, Lu, Kaimei, Ma, Hanxiang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183661/
https://ncbi.nlm.nih.gov/pubmed/32334510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12871-020-01013-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados